Literature DB >> 19110023

T-cell-derived cytokines, nitric oxide production by peripheral blood monocytes and seric anti-Leishmania (Leishmania) chagasi IgG subclass patterns following immunization against canine visceral leishmaniasis using Leishvaccine and Leishmune.

Márcio Sobreira Silva Araújo1, Renata Aline de Andrade, Renato Sathler-Avelar, Andréa Teixeira-Carvalho, Mariléia Chaves Andrade, Leonardo Rocha Vianna, Wilson Mayrink, Alexandre Barbosa Reis, Luiz Cosme Cotta Malaquias, Maria Norma Mello, Olindo Assis Martins-Filho.   

Abstract

It is generally accepted that distinct cytokine expression by the cellular immune response plays a critical role during the outcome of experimental as well as natural canine visceral Leishmaniasis (CVL). Despite the fact that immunoprophylaxis of CVL has become an important control strategy and protective immunity has been reported upon immunization with whole as well as purified Leishmania antigens, the cytokine profile of T-cells triggered by anti-CVL vaccines still remain to be determined. Herein, we have developed a cross-sectional analysis of German Shepherd dogs submitted to vaccination protocols with Leishvaccine (n=6) and Leishmune (n=6). Our data identified distinct immunological profiles elicited by Leishvaccine and Leishmune, with the Leishvaccine triggering a mixed, IFN-gamma and IL-4, cytokine pattern in addition to high levels of anti-Leishmania IgG1, whereas the Leishmune induced an immunological pattern characterized by enhanced levels of IFN-gamma, NO and anti-Leishmania chagasi IgG2. It was important to notice that despite the distinct immunological patterns triggered by Leishvaccine and Leishmune, the ability of both immunobiologicals to activate T-cell-derived IFN-gamma synthesis further suggesting their immunogenic potential against CVL. These findings added support to our hypothesis that both antigenic composition (whole antigen in Leishvaccine versus purified antigen in Leishmune) as well as the adjuvant nature (BGC and saponin) used for the vaccine formulation may count for the distinct activation pattern observed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19110023     DOI: 10.1016/j.vaccine.2008.11.104

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  19 in total

1.  Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis.

Authors:  Ankita Thakur; Harpreet Kaur; Sukhbir Kaur
Journal:  Med Microbiol Immunol       Date:  2014-11-29       Impact factor: 3.402

Review 2.  The immunopathology of canine vector-borne diseases.

Authors:  Michael J Day
Journal:  Parasit Vectors       Date:  2011-04-13       Impact factor: 3.876

Review 3.  One Health: the global challenge of epidemic and endemic leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa; Michael J Day
Journal:  Parasit Vectors       Date:  2011-10-10       Impact factor: 3.876

4.  One-year timeline kinetics of cytokine-mediated cellular immunity in dogs vaccinated against visceral leishmaniasis.

Authors:  Christiane Costa-Pereira; Marcela L Moreira; Rodrigo P Soares; Bruno H Marteleto; Vitor M Ribeiro; Michelle H França-Dias; Ludmila M Cardoso; Kelvinson F Viana; Rodolfo C Giunchetti; Olindo A Martins-Filho; Márcio S S Araújo
Journal:  BMC Vet Res       Date:  2015-04-11       Impact factor: 2.741

5.  LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.

Authors:  Rodrigo Dian de Oliveira Aguiar-Soares; Bruno Mendes Roatt; Henrique Gama Ker; Nádia das Dores Moreira; Fernando Augusto Siqueira Mathias; Jamille Mirelle de Oliveira Cardoso; Nelder Figueiredo Gontijo; Oscar Bruna-Romero; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Rodrigo Corrêa-Oliveira; Rodolfo Cordeiro Giunchetti; Alexandre Barbosa Reis
Journal:  Parasit Vectors       Date:  2014-02-07       Impact factor: 3.876

6.  Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.

Authors:  Lucilene Aparecida Resende; Rodrigo Dian de Oliveira Aguiar-Soares; Henrique Gama-Ker; Bruno Mendes Roatt; Ludmila Zanandreis de Mendonça; Marina Luiza Rodrigues Alves; Denise da Silveira-Lemos; Rodrigo Corrêa-Oliveira; Olindo Assis Martins-Filho; Márcio Sobreira Silva Araújo; Ricardo Toshio Fujiwara; Nelder Figueiredo Gontijo; Alexandre Barbosa Reis; Rodolfo Cordeiro Giunchetti
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

7.  Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.

Authors:  Bruno Mendes Roatt; Rodrigo Dian de Oliveira Aguiar-Soares; Juliana Vitoriano-Souza; Wendel Coura-Vital; Samuel Leôncio Braga; Rodrigo Corrêa-Oliveira; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Marta de Lana; Nelder Figueiredo Gontijo; Marcos José Marques; Rodolfo Cordeiro Giunchetti; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

8.  Vaccines for canine leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

9.  Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection.

Authors:  Dirlei Nico; Daniele Crespo Gomes; Iam Palatnik-de-Sousa; Alexandre Morrot; Marcos Palatnik; Clarisa Beatriz Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2014-06-11       Impact factor: 7.561

10.  Application of rapid in vitro co-culture system of macrophages and T-cell subsets to assess the immunogenicity of dogs vaccinated with live attenuated Leishmania donovani centrin deleted parasites (LdCen-/-).

Authors:  Kelvinson Fernandes Viana; Jacqueline Araújo Fiuza; Sreenivas Gannavaram; Ranadhir Dey; Angamuthu Selvapandiyan; Daniella Castanheira Bartholomeu; Denise da Silveira-Lemos; Lilian Lacerda Bueno; Walderez Ornelas Dutra; Ricardo Toshio Fujiwara; Hira L Nakhasi; Rodolfo Cordeiro Giunchetti
Journal:  Parasit Vectors       Date:  2016-04-30       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.